Get started
Author

Brijendra Kumar Srivastava

Observed names: BRIJENDRA SRIVASTAVA, Brijendra Kumar Srivatsava, Brijendra Srivastava, BrijendraKumar Srivastava
ORCID: 0009-0000-5559-9055
Observed ORCID: 0009-0000-5559-9055
OpenAlex ID: A5110529137
Glycemic parameters in patients with new-onset diabetes during COVID-19 pandemic are more severe than in patients with new-onset diabetes before the pandemic: NOD COVID India Study
2020 · Amerta Ghosh, Ranjit Mohan Anjana, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 70
PDF
Prevalence of Hepatic Steatosis and Fibrosis in Asian Indian Individuals with Type 2 Diabetes
2025 · Khandhulwa Chandramouli Bhuvanesswar, Brijendra Kumar Srivastava, et al. · Diabetes Therapy · 9
PDF
Systemic Factors Affecting Diabetic Retinopathy
2018 · BrijendraKumar Srivastava, B Ramya, et al. · Journal of Diabetology · 9
Short-term insulin therapy at the time of diagnosis of Type 2 diabetes leads to better glycemic control and improved beta cell function
2019 · Viswanathan Mohan, Siddharth Madnani, et al. · Journal of Diabetology · 7
Judicious use of modern technology with antihyperglycemic agents: The changing landscape of type 2 diabetes management
2024 · Brijendra Kumar Srivastava, Ranjit Mohan Anjana, et al. · Journal of Diabetology · 3
Abstract #221 Combination Therapy with Once Weekly GLP 1 Receptor Agonist Dulaglutide and SGLT2 Inhibitors in Asian Indians with Type 2 Diabetes
2018 · Brijendra Srivastava, M. Deepa, et al. · Endocrine Practice · 2
Imaging Modalities for Hepatic Steatosis and Fibrosis in Type 2 Diabetes Mellitus: A Review Article
2025 · Varun Damle, Akarshan Sharma, et al. · Journal of Diabetology · 1
Acute Kidney Injury Associated With Finerenone Use in Type 2 Diabetes Mellitus Patients: A Case Report
2025 · Brijendra Kumar Srivastava, Ranjit Mohan Anjana, et al. · Journal of Diabetology · 1
Association of acute pancreatitis in a patient with Type 1 diabetes
2017 · BrijendraKumar Srivastava, M Meera, et al. · Journal of Diabetology · 1
Severe insulin resistance with diabetic ketoacidosis and subacute pancreatitis in type 2 diabetes: a case report
2026 · Brijendra Kumar Srivastava, Akarshan Sharma, et al. · International Journal of Diabetes in Developing Countries
Treatment Modalities for Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Review Article
2026 · Varun Damle, Akarshan Sharma, et al. · Journal of Diabetology
#1706120 Effect of combination therapy with once weekly Dulaglutide and Empagliflozin on noninvasive liver scores: real world experience from India
2024 · Brijendra Srivastava, BRIJENDRA SRIVASTAVA, et al. · Endocrine Practice
PDF
#1706090 Initial experience with Minimed 780G system in type 2 diabetic individuals at a tertiary diabetes centre in south India
2024 · Brijendra Srivastava, BRIJENDRA SRIVASTAVA, et al. · Endocrine Practice
Abstract #1402867: Association of Corneal Sensitivity with Indian Diabetes Risk Score in Asian Indians The Chennai Urban Rural Epidemiology Study (Cures)
2023 · Brijendra Kumar Srivastava, M. Deepa, et al. · Endocrine Practice
PDF
Abstract #1184266: ASSOCIATION OF TRIGLYCERIDE AND GLUCOSE (TyG) INDEX WITH CAROTID INTIMAL MEDIAL THICKNESS (IMT) IN APPERANTLY HEALTHY SUBJECTS : THE CHENNAI URBAN RURAL EPIDEMIOLOGY STUDY (CURES)
2022 · Brijendra Srivastava, M. Deepa, et al. · Endocrine Practice
Abstract #1003759: Hypertriglyceridemia in Indian Context: A Potential Beneficial Intervention Needed in The High-Risk Modifiable Group (HRMG)
2021 · Brijendra Srivastava, M. DEEPA, et al. · Endocrine Practice
Combination Therapy With Premixed & Basal Insulin Analogues in Asian Indians With Type 2 Diabetes
2021 · Brijendra Kumar Srivastava, R M Anjana, et al. · Journal of the Endocrine Society
PDF
Abstract #805134: Effect of FIASP on Glycaemic Targets in Type 2 Diabetic Subjects, When Used in the Medtronic Minimed 640G Continuous Subcutaneous Insulin Infusion (CSII) Pump
2020 · Brijendra Srivastava · Endocrine Practice
Abstract #805218: Combination Therapy with Once Weekly GLP 1 Receptor Agonist Dulaglutide and Basal Insulin Analogues in Asian Indians with Type 2 Diabetes
2020 · Brijendra Srivastava · Endocrine Practice
The role of hydroxychloroquine in COVID-19: Where do we stand?
2020 · RanjitMohan Anjana, NadimintyGanapathi Sastry, et al. · Journal of Diabetology
Abstract #215 Association of Corneal Sensitivity with Carotid Intimal Medial Thickness (IMT) in Asian Indian Type 2 Diabetic Subjects the Chennai Urban Rural Epidemiology Study (Cures)
2018 · Brijendra Srivastava, M. Deepa, et al. · Endocrine Practice
Leveraging big data using a novel clinical database and analytic platform based on 323,145 individuals with and without of Diabetes
2017 · Anjana Ranjit Mohan, Praveen Raj, et al. · Canadian Journal of Biotechnology
PDF
Abstract #233: Pre-Impaired Glucose Tolerance, a Risk Factor for Diabetes Progression in Asian Indians
2015 · Brijendra Srivastava, Deepa Mohan, et al. · Endocrine Practice
The MDRF- ADA post graduate course in diabetology - scientific highlights
2003 · Brijendra Kumar Srivatsava, Muthuswamy Balasubramanyam, et al.
Insulin - a vasoactive hormone
2002 · Brijendra Srivastava, Viswanathan Mohan
Works count: 27
Citation count: 103
H-index: 4
I10-index: 1
Year
Topic
Type